Biologics in Folliculitis Decalvans : an Adaptative Trial Research
NCT07268534
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Folliculitis Decalvans (FD)
Interventions
DRUG:
Adalimumab
DRUG:
Ustekinumab
DRUG:
Baricitinib
Sponsor
Assistance Publique - Hôpitaux de Paris